Sensyne app used to help assess feasibility of rapid Covid-19 tests in the community

Clinical AI company Sensyne Health has announced that its CVm-Health+™ app will be used in a study to evaluate rapid Covid-19 testing in the community. The FACTS study, developed by the University of Oxford in partnership with the Department of Health and Social Care, Public Health England and Durham University, will assess the feasibility of…

You must be a HM Subscriber to view this content.

Subscribe Now »